Objective: Patients suffering from bacterial infections of the lungs are frequently treated by alternating or combining the inhaled antibiotics tobramycin (aminoglycoside) and colistimethate-sodium (CMS, i.e. polymyxin E). Therefore, patients might feel encouraged to mix solutions of both antibiotics in order to inhale the mixture in one single inhalation session. As the effects of preparing such a mixture on physical and chemical stability of the solution are not known, an evaluation was triggered. Methods: Vials of tobramycin solution (170 mg/1.7 ml) were mixed with reconstituted CMS (2 Mio. IU CMS dissolved in 4 ml of 0.9% saline) and physicochemically characterized with respect to osmolality, viscosity, surface tension and pH. Additionally, the tobramycin content and possible tobramycin related impurities were assayed by HPLC.
